Tamilarasan Neelakandan, Yasmin Begum M, Anitha Posina, Umme Hani, Cheng Wan Hee, Mohan Sellapan, Ramkanth Sundarapandian, Janakiraman Ashok Kumar
Department of Pharmaceutics, Karpagam College of Pharmacy, Coimbatore 641032, TN, India.
Department of Pharmaceutics, King Khalid University, Abha 62529, Saudi Arabia.
Nanomaterials (Basel). 2022 Aug 26;12(17):2954. doi: 10.3390/nano12172954.
Transferosomes are one of the vesicular carriers that have received extensive research and attention recently because of their capacity to get beyond the barriers posed by the stratum corneum to penetration. The intent of the current study is to optimize and evaluate proanthocyanidin (PAC) containing transferosomal transdermal gels. PAC-containing transferosomes were prepared using the film hydration method and then loaded into a 4% methylcellulose gel. A 2 Box-Behnken design was used to optimize the PAC-loaded transferosomal gel, where the effects of phospholipid 90 G (X1), Tween 80 (X2), and sonication time (X3) were evaluated. The formulation factors, such as the drug entrapment efficiency percentage (PEE) and drug release, were characterized. A PEE of 78.29 ± 1.43% and a drug release in vitro at 6 h of 24.2 ± 1.25% were obtained. The optimized transferosomal-loaded proanthocyanidin (OTP) formulation penetrated the porcine skin at an excellent rate (0.123 ± 0.0067 mg/cm/h). Stability tests were conducted for OTP to predict the effects of various temperature conditions on the physical appearance, drug content, and PEE for periods of 15, 30, and 45 days. Finally, this transferosomal system for transdermal PAC delivery may be a suitable alternative to the conventional treatment for osteoarthritis.
传递体是近年来受到广泛研究和关注的囊泡载体之一,因为它们能够突破角质层造成的渗透屏障。本研究的目的是优化和评估含有原花青素(PAC)的传递体透皮凝胶。采用薄膜水化法制备含PAC的传递体,然后将其载入4%的甲基纤维素凝胶中。采用二因素五水平的Box-Behnken设计优化载PAC传递体凝胶,评估磷脂90G(X1)、吐温80(X2)和超声处理时间(X3)的影响。对制剂因素,如药物包封率(PEE)和药物释放进行了表征。获得了78.29±1.43%的PEE和6小时体外24.2±1.25%的药物释放率。优化的载原花青素传递体(OTP)制剂以优异的速率(0.123±0.0067mg/cm/h)穿透猪皮。对OTP进行了稳定性试验,以预测不同温度条件对其外观、药物含量和PEE在15、30和45天期间的影响。最后,这种用于透皮递送PAC的传递体系统可能是骨关节炎传统治疗的合适替代方案。